Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.3.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LU.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
LU.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LF.3.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
LF.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ML.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
ML.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KP.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.1.6NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KP.3.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KP.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.1.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KP.3.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
LB.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KP.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MM.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
MM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.7.8NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JN.1.7.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.3.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KP.2.3.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
LB.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.2.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KP.3.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.7NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
LB.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.16.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JN.1.16.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LW.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
LW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LP.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
LP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.2.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
LB.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.3.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KP.3.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.1.5.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FL.1.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JF.1.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JF.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.8NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
GK.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JD.1.1.8NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JD.1.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used